Abstract
Purpose: To determine whether the results of triple-test analysis differ between spontaneous and IVF pregnancies.
Methods: The study population consisted of 140 women with singleton pregnancies, 70 by IVF, and 70 by spontaneous conception. The groups were matched for maternal age, gestational week, and laboratory batch. The levels of all triple-test markers—alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and unconjugated estriol (u-E3)—were compared between the groups.
Results: Significantly higher HCG levels were detected in the patients with IVF pregnancies than in the control group (1.31 ± 0.8 vs. 0.95 ± 0.5 multiple of the medians, respectively, (p < 0.006), but there were no significant differences in AFP or u-E3 levels. Overall, 18.5% of the IVF group were found to be screen-positive as compared with 11.4% of the control group (difference not statistically significant). Only 8 IVF pregnancies (11.4%) reached the lowest calculated risk possible (1:9999) compared with 17 (24.2%) in the control group (p < 0.05).
Conclusions: Our findings support previous data demonstrating elevated maternal serum HCG in IVF patients in comparison with spontaneous ones.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Hay DL: Placental histology and the production of human choriogonadotropin and its subunits in pregnancy. Br J Obstet Gynaecol 1988;95:1268-1275
Seppala M, Ruoslahit E: Alpha-fetoprotein: Physiology and pathology during pregnancy and application to antenatal diagnosis. J Perinat Med 1973;1:104-108
Cuckle HS, Wald NJ, Thompson S: Estimating a woman's risk for having a pregnancy associated with Down syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987;94:387-402
Wald NJ, Cuckle HS, Densem JW, Nanchah K, Royston P, Chard T: Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 1988;297:883-887
Canick JA, Shanininian KA, Haning RV, Hackett R: Maternal serum screening in singleton in vitro fertilization pregnancies. (Abstract). Am J Obstet Gynecol 1993;170:349
Muller F, Aegerter P, Boue A: Prospective maternal serum humanchorionic gonadotropin screening for the risk of fetal chromosome anomalies and subsequent fetal and neonatal deaths. Prenat Diagn 1993;13:29-43
Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H: Down syndrome screening marker levels following assisted reproduction. Prenat Diagn 1996;16:111-114
Bar-Hava I, Ashkenazi J, Shelef M: Morphology and clinical outcomes of embryos after in vitro fertilization are superior to those after intracytoplasmic sperm injection. Fertil Steril 1997;68:653-657
Heinonen S, Ruunanen M, Kirkinen P, Hippelainen M, Saarikoski S: Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril 1996;66:398-403
Ribbert LSM, Kornman LH, De Wolf BTHM, Simons AHM, Jansen CAM, Beekhuis JR: Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn 1996;16:35-38
Merkatz IR, Nitowsky HM, Macri JN, Johnson WE: An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-891
Marrs RP, Kletzky OA, Howard WF, Mishell DR: Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol 1979;135:731-736
Frishman GN, Canick JA, Hugan JW: Serum triplemarker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 1997;90:98-101
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bar-Hava, I., Yitzhak, M., Krissi, H. et al. PREGNANCY: Triple-Test Screening in In Vitro Fertilization Pregnancies. J Assist Reprod Genet 18, 228–231 (2001). https://doi.org/10.1023/A:1009455912670
Issue Date:
DOI: https://doi.org/10.1023/A:1009455912670